Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Las Vegas Metropolitan Police Signs Five-Year WrapReality™ Contract Renewal with WRAP® to Advance Immersive Training and Non-Lethal Response™ Preparedness
-
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
-
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
-
CVG Announces First Quarter 2026 Earnings Call
-
Arteris to Announce Financial Results for the First Quarter 2026 on Tuesday, May 12, 2026
-
Kaltura Puts the AI CEO Into Production With Ron Yekutiel’s Digital Twin, Using the Same Agentic Avatar Tech It Offers Enterprises
-
Kestra Showcases Accelerated Innovation at HRS 2026
-
Stereotaxis Announces First MAGiC Procedures in the United States
-
The Invoicing “Time Tax”: Why 5 Hours of Manual Work is Now the Leading Predictor of Small Business Cash-Flow Risk
-
Volatus Aerospace Appoints Major General (Ret’d) Peter “Pete” Fesler to Advisory Board; Lieutenant-General (Ret’d) Andrew Leslie to Chair
-
BitDelta Group CEO Dr. Demetrios Zamboglou Visits India as BitDelta India Begins Operations
-
RenX Enterprises Expects First Quarter 2026 Revenue of More Than $3.5 Million
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Borregaard ASA: Issuance of Commercial Paper
-
Form 8.5 (EPT/RI) - Alternative Income REIT Plc
-
Dynacor Provides Expansion and Corporate Update
-
The Distillery Historic District announces opening of The Cooperage Marketplace
-
Stock Yards Bancorp Reports First Quarter Earnings of $36.6 Million or $1.24 Per Diluted Share
-
RenX Enterprises Expects First Quarter 2026 Revenue of More Than $3.5 Million
-
ASML discloses 2026 AGM results
-
Viomi Technology Co., Ltd Filed 2025 Annual Report on Form 20-F
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
-
WEBUY GLOBAL LTD. Announces Record-Breaking Performance For the Company at NATAS Fair March 2026 with Over US$3.34 Million in Travel Bookings
-
Lead Service Line Replacement Cost Calculator Featured on United Nations South-South Galaxy Platform
-
QGold Announces Acceleration of Warrant Expiry Dates
-
Repligen to Report First Quarter 2026 Financial Results
-
BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
-
Arq Schedules First Quarter 2026 Earnings Conference Call
-
Habit Celebrates Newest Restaurant Launch in Reseda, California
-
LexisNexis® CounselLink® Releases 2026 Trends Report as Rising Rates and Big Law Share of Wallet Continue to Climb
-
Big Bear Gold Corp. Completes Shares for Debt Settlements
-
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call
-
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
-
Holding(s) in Company
-
Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
-
Caliber Advances Hyatt Studios Development Platform Across Three High-Growth Markets
-
Pecoy Copper Completes Magnetotelluric Survey to Optimize High-Priority Targeting and Resource Expansion
-
Growscape Launches Revolutionary EarthSafe Sustainability Platform, Setting New Industry Standard
-
Storaktionærmeddelelse
-
Landsbankinn hf.: Financial results for Q1 2026 to be published 30 April 2026
-
Balchem Corporation Releases 2025 Sustainability Report
-
Luminoah Announces FDA Clearance of the Luminoah Flow Enteral Nutrition System, A Brighter Future for Tube Feeding
-
From Lab to Field: HPQ and Novacium Secure First Battery Order from European Drone Manufacturer Using GEN4 Cells
-
Emerita Intersects High Grade Zone of 4.9m Containing Mineralization Grading 3.5% Copper, 1.95 g/t Gold and 95.63 g/t Silver at El Cura
-
NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs
-
Allpoints Services Names Longtime Homebuilding Executive John Ballard as CRO
-
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
-
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
-
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026

